BioSpace News Archive

Drug Development

Emalex Biosciences Publishes Phase 2b Results for Tourette Syndrome Candidate in Pediatrics

A Phase 2b clinical trial involving more than 150 children and adolescents with Tourette syndrome found ecopipam significantly reduced the total number of tics compared to placebo, according to a study published today in the journal Pediatrics.

January 11, 2023
·
4 min read
Brightwork Health IT Appoints Eliza Corrigan as Chief Sales Officer

Leading technology consultancy for the healthcare industry hires experienced health IT executive to lead its sales operations

January 11, 2023
·
3 min read
Biotech Bay

StemExpress Launches CellsExpress Bulk Cell Isolation

As a trusted provider of high-quality isolated human stem and immune cells for over a decade, StemExpress is now proud to offer select isolated products in bulk through their CellsExpress service.

January 11, 2023
·
2 min read
Job Trends

Press Release: Sanofi Ventures announces multi-year capital commitment from Sanofi, increasing evergreen fund to $750M

Paris, January 11,2023 Sanofi Ventures has announced an additional multi-year commitment from Sanofi, with an increase in capital to more than $750 million to the evergreen venture fund.

January 11, 2023
·
5 min read
Ice Global Consulting, Inc. Completes Acquisition of Epicenter™ Technology

ICE Global Consulting, Inc. (ICE Global) announced today that it has entered into an asset purchase agreement to acquire all operating assets related to the Epicenter™ contracts management technology from Journey CTS, LLC.

January 11, 2023
·
2 min read
Business

The American Diabetes Association Welcomes 2023 Principal Officers and New Members to the National Board of Directors

The American Diabetes Association® welcomes the 2023 Principal Officers and Board of Directors.

January 11, 2023
·
16 min read
Business

Baxter to Host Fourth-Quarter 2022 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2022 financial results on Thursday, February 9, 2023 at 7:30 a.m. Central Time.

January 11, 2023
·
1 min read
Pharm Country

Amarin Comments on Sarissa’s Notice to Call a Special Meeting of Amarin Shareholders

Amarin Corporation plc confirmed receipt of a requisition by Sarissa Capital Management LP to convene a General Meeting of Shareholders.

January 11, 2023
·
11 min read
Business

Mountain Valley MD Announces Transition of Chief Medical Officer to Advisory Role

Mountain Valley MD Holdings Inc. announced that Dr. Azhar Rana, the Company’s Chief Medical Officer, will be transitioning to an advisory capacity effective February 1, 2023.

January 11, 2023
·
4 min read
Business

PAVmed and Lucid Diagnostics to Provide Strategic Business Update

PAVmed Inc. and its majority-owned subsidiaries Lucid Diagnostics Inc. and Veris Health Inc. today announced they will hold a joint conference call to provide a strategic business update on Tuesday, January 17, 2023 at 4:30PM EDT.

January 11, 2023
·
4 min read